中文别名:
化合物LIFIRAFENIB (BGB-283);5-(((1R,1AS,6BR)-1-(6-(三氟甲基)-1H-苯并[D]咪唑-2-基)-1A,6B-二氢-1H-环丙并[B]苯并呋喃-5-基)氧基)-3,4-二氢-1,8-萘啶-2(1H)-酮
英文别名:
5-((1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one;EOS-60483;Lifirafenib;BGB-283;BEIGENE-283;Beigene-283;1,8-Naphthyridin-2(1H)-one, 5-[[(1R,1aS,6bR)-1a,6b-dihydro-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-cyclopropa[b]benzofuran-5-yl]oxy]-3,4-dihydro-